Long-term outcomes of psychoactive drug use in trauma patients: A multicenter patient-reported outcomes study

J Trauma Acute Care Surg. 2021 Feb 1;90(2):319-324. doi: 10.1097/TA.0000000000003032.

Abstract

Introduction: Psychoactive drug use (PDU) is reported in up to 40% of trauma patients and is associated with a higher rate of in-hospital complications. However, little is known about its long-term impact on trauma patients. We aimed to assess the long-term functional, mental, and psychosocial outcomes of PDU in trauma patients 6 to 12 months after injury.

Methods: Trauma patients with moderate to severe injuries (Injury Severity Score, >9) who had a toxicology screen upon admission to one of three level 1 trauma centers were contacted by phone 6 to 12 months postinjury. Psychoactive drug use was defined as the presence of a psychoactive, nonprescribed substance on toxicology screen including amphetamine, barbiturate, benzodiazepine, cannabinoid, methamphetamine, methadone, opioid, oxycodone, methylenedioxymethamphetamine (ecstasy), phencyclidine, tricyclic antidepressant, and cocaine. The interviews systematically evaluated functional limitations, social functioning, chronic pain, and mental health (posttraumatic stress disorder, depression, anxiety). Patients with a score of ≤47 on the Short-Form Health Survey version 2.0 social functioning subdomain were considered to have social dysfunction. Multivariable regression models were built to determine the independent association between PDU and long-term outcomes.

Results: Of the 1,699 eligible patients, 571 (34%) were included in the analysis, and 173 (30.3%) screened positive for PDU on admission. Patients with PDU were younger (median age [interquartile range], 43 [28-55] years vs. 66 [46-78] years, p < 0.001), had more penetrating injuries (8.7% vs. 4.3%, p = 0.036), and were less likely to have received a college education (41.3% vs. 54.5%, p = 0.004). After adjusting for patients' characteristics including the presence of a baseline psychiatric comorbidity, patients with PDU on admission were more likely to suffer from daily chronic pain, mental health disorders, and social dysfunction 6 to 12 months after injury. There was no difference in the functional limitations between patients with and without PDU.

Conclusion: On the long term, PDU in trauma patients is strongly and independently associated with worse mental health, more chronic pain, and severe impairment in social functioning. A trauma hospitalization presents an opportunity to identify patients at risk and to mitigate the long-term impact of PDU on recovery.

Level of evidence: Prognostic/epidemiologic, level III.

Publication types

  • Multicenter Study

MeSH terms

  • Activities of Daily Living / psychology
  • Chronic Pain* / diagnosis
  • Chronic Pain* / etiology
  • Duration of Therapy
  • Female
  • Functional Status
  • Humans
  • Injury Severity Score
  • Long Term Adverse Effects* / chemically induced
  • Long Term Adverse Effects* / diagnosis
  • Long Term Adverse Effects* / epidemiology
  • Long Term Adverse Effects* / prevention & control
  • Male
  • Mental Health / statistics & numerical data*
  • Middle Aged
  • Prognosis
  • Psychotropic Drugs* / administration & dosage
  • Psychotropic Drugs* / adverse effects
  • Psychotropic Drugs* / classification
  • Quality of Life*
  • Social Interaction / drug effects*
  • Toxicity Tests / methods
  • Toxicity Tests / statistics & numerical data
  • United States / epidemiology
  • Wounds and Injuries* / complications
  • Wounds and Injuries* / drug therapy
  • Wounds and Injuries* / psychology
  • Wounds and Injuries* / rehabilitation

Substances

  • Psychotropic Drugs